Condition

Metastatic Castrate Resistant Prostate Cancer clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Treatment of advanced prostate cancer with XNW5004 and enzalutamide

  This study tests if combining the drugs XNW5004 and enzalutamide can help men with advanced prostate cancer that hasn't responded to other hormone treatments.

  Recruiting at 2 sites Phase 1/2 Evopoint Biosciences Inc. · Jinan, Shandong and 1 other locations · NCT06702995

• Comparing Carboplatin and Olaparib for Prostate Cancer with DNA Repair Mutations

  This study is testing whether carboplatin or olaparib works better for men with advanced prostate cancer who have certain DNA repair mutations.

  Recruiting at 15 sites Phase 2 VA Office of Research and Development · West Los Angeles, California and 17 other locations · NCT04038502

Related topics

Quick answers

How many Metastatic Castrate Resistant Prostate Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →